OTCMKTS:FSDDFFSD Pharma Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.06 -0.71 (-18.83 %) (As of 04/3/2020 04:00 PM ET) Add Compare Share Today's Range$2.75Now: $3.06▼$3.7650-Day Range$2.55MA: $4.36▼$6.0052-Week Range$3.43Now: $3.06▼$68.66Volume73,323 shsAverage Volume6,994 shsMarket Capitalization$23.19 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartEarningsHeadlinesSocial Media FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of the indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products. FSD Pharma Inc. is headquartered in Cobourg, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for FSD Pharma. Previous Next 3.2 Community Rank Outperform VotesFSD Pharma has received 35 “outperform” votes. (Add your “outperform” vote.)Underperform VotesFSD Pharma has received 19 “underperform” votes. (Add your “underperform” vote.)Community SentimentFSD Pharma has received 64.81% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about FSD Pharma and other stocks. Vote “Outperform” if you believe FSDDF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FSDDF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldFSD Pharma does not currently pay a dividend.Dividend GrowthFSD Pharma does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, FSD Pharma insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.43% of the stock of FSD Pharma is held by institutions. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.64 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:FSDDF Previous Symbol CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current Ratio1.81 Quick Ratio1.60Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$70,000.00 Price / Sales331.35 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares7,580,000Market Cap$23.19 million Next Earnings DateN/A OptionableNot Optionable Receive FSDDF News and Ratings via Email Sign-up to receive the latest news and ratings for FSDDF and its competitors with MarketBeat's FREE daily newsletter. OTC:FSDDF Rates by TradingView FSD Pharma (OTCMKTS:FSDDF) Frequently Asked Questions How has FSD Pharma's stock been impacted by COVID-19 (Coronavirus)? FSD Pharma's stock was trading at $4.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, FSDDF stock has decreased by 28.0% and is now trading at $3.06. View which stocks have been mosted impacted by Coronavirus. Has FSD Pharma been receiving favorable news coverage? News articles about FSDDF stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. FSD Pharma earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutFSD Pharma. Who are some of FSD Pharma's key competitors? Some companies that are related to FSD Pharma include Neptune Wellness Solutions (NEPT), Itamar Medical (ITMR), ESSA Pharma (EPI), REDHILL BIOPHAR/S (RDHL), Venus Concept (VERO), Spectral Medical (EDT), Ampliphi Biosciences (APHB), OncoCyte (OCX), Fennec Pharmaceuticals (FENC), Milestone Scientific (MLSS), Enzo Biochem (ENZ), Soleno Therapeutics (SLNO), RenovaCare (RCAR), 1300 Smiles (ONT) and Liberty Health Sciences (LHSIF). What other stocks do shareholders of FSD Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include Canopy Growth (CGC), Emerald Health Therapeutics (EMHTF), FSD Pharma (HUGE), Supreme Cannabis (SPRWF), Netflix (NFLX), OrganiGram (OGI), Cross Timbers Royalty Trust (CRT), Pyxus International (PYX), Cannabix Technologies (BLOZF) and Charlotte's Web (CWBHF). Who are FSD Pharma's key executives? FSD Pharma's management team includes the following people: Mr. Anthony John Durkacz, Founder & Co-Chairman (Age 43)Dr. Raza Bokhari M.B.A., MBA, Exec. Co-Chairman & Interim CEO (Age 51)Mr. Zeeshan Saeed, Founder, Pres & DirectorMr. Donal Carroll, Interim CFODr. Sara May, Pres of FV Pharma What is FSD Pharma's stock symbol? FSD Pharma trades on the OTCMKTS under the ticker symbol "FSDDF." How do I buy shares of FSD Pharma? Shares of FSDDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is FSD Pharma's stock price today? One share of FSDDF stock can currently be purchased for approximately $3.06. How big of a company is FSD Pharma? FSD Pharma has a market capitalization of $23.19 million and generates $70,000.00 in revenue each year. View additional information about FSD Pharma. This page was last updated on 4/4/2020 by MarketBeat.com StaffFeatured Article: Green Investing
